Alpha 2.0
Login Register
» Authors » G S Tang

G S Tang

Explore the profile of G S Tang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 18
Followers 0
Related Specialties
Hematology
Allergy & Immunology
Top 10 Co-Authors
J M Wang
X X Hu
J M Yang
W P Zhang
X Ni
L Gao
J Chen
A J Huang
H Cheng
L Chen
Published In
Zhonghua Xue Ye Xue Za Zhi
Clin Exp Immunol
Affiliations
Soon will be listed here.
Recent Articles
1.
[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms]
Zhang M, Bao M, Shi D, Shi H, Liu X, Xu N, et al.
Zhonghua Xue Ye Xue Za Zhi . 2023 Jun; 44(3):193-201. PMID: 37356980
To investigate the clinical and genetic features of young Chinese patients with myeloproliferative neoplasms (MPN). In this cross-sectional study, anonymous questionnaires were distributed to patients with MPN patients nationwide. The...
2.
[Spectrum of gene mutations and clinical features in adult acute myeloid leukemia with normal karyotype]
Huang A, Gao L, Ni X, Hu X, Tang G, Cheng H, et al.
Zhonghua Xue Ye Xue Za Zhi . 2022 Jul; 42(5):420-424. PMID: 35790467
No abstract available.
3.
[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms]
Bao M, Shi D, Shi H, Liu X, Duan M, Zhuang J, et al.
Zhonghua Xue Ye Xue Za Zhi . 2022 Jan; 42(12):985-992. PMID: 35045668
To explore health-related quality of life (HRQoL) and identify its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms (MPNs) . In this cross-sectional study, anonymous questionnaires were distributed to...
4.
[Rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma: a case report and literature review]
Huang A, Ni X, Fu W, Zhang Y, Tang G, Wang J
Zhonghua Xue Ye Xue Za Zhi . 2021 May; 42(4):338-342. PMID: 33979980
No abstract available.
5.
[Prognostic significance of minimal residual disease before post-remission therapy in younger adult acute myeloid leukemia patients with intermediate risk and negative of FLT3-ITD, NPM1 and biallelic CEBPA mutations]
Zhang Y, Zhang Y, Zhang Y, Tang G, Zhang W, Yang J, et al.
Zhonghua Xue Ye Xue Za Zhi . 2020 May; 40(7):597-601. PMID: 32397025
No abstract available.
6.
[Risk-factors analysis of graft failure after allogeneic hematopoietic stem cell transplantation]
Fei Y, Hu X, Chen Q, Huang A, Cheng H, Ni X, et al.
Zhonghua Xue Ye Xue Za Zhi . 2020 Feb; 41(1):64-68. PMID: 32023757
No abstract available.
7.
[Effect of consolidation before allogeneic hematopoietic stem cell transplantation for non-favorable acute myeloid leukemia patients with first complete remisson and negative minimal residual disease]
Zhang Y, Zhang Y, Ni X, Gao L, Qiu H, Zhang Y, et al.
Zhonghua Xue Ye Xue Za Zhi . 2020 Feb; 41(1):16-22. PMID: 32023749
To probe the prognostic value of consolidation chemotherapy in non-favorable acute myeloid leukemia (AML) patients who were candidates for allogeneic hematopoietic stem cell transplantation (allo-HSCT) with first complete remission (CR(1))...
8.
[Prognostic value of donor chimerism at +90 days after allogeneic hematopoietic stem cell transplantation in young patients with intermediate-risk acute myeloid leukemia]
Fei Y, Hu X, Chen Q, Huang A, Cheng H, Ni X, et al.
Zhonghua Xue Ye Xue Za Zhi . 2020 Feb; 40(12):990-995. PMID: 32023728
To investigate the relationship between donor chimerism and relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) . The clinical data of 105 patients with acute myeloid leukemia (AML) who underwent...
9.
[Repeated fever with cytopenia]
Gao L, Wang Y, He M, Tang G, Hu X, Yang D, et al.
Zhonghua Xue Ye Xue Za Zhi . 2019 Dec; 40(11):962-964. PMID: 31856450
No abstract available.
10.
[Efficacy of Hyper-CVAD/MA and CHALL-01 regimens in the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia patients under 60 years old]
Huang A, Wang L, Du J, Tang G, Cheng H, Gong S, et al.
Zhonghua Xue Ye Xue Za Zhi . 2019 Sep; 40(8):625-632. PMID: 31495127
To compare the difference of efficacy between traditional Hyper-CVAD/MA regimen and the adolescents inspired chemotherapy regimen, CH ALL-01, in treatment of adult Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+) ALL) ....